Figure 1From: HIVAN and medication use in chronic dialysis patients in the United States: analysis of the USRDS DMMS Wave 2 studySurvival, Dialysis Morbidity and Mortality Wave II Cohort (DMMS II), 1996 only, N = 3374, patients with Human Immunodeficiency Virus (HIV) associated nephropathy (HIVAN) vs. patients with other causes of end stage renal disease (ESRD), p < 0.01 by Log Rank Test.Back to article page